Skip to content

X Linked Cerebral Adrenoleukodystrophy C2026514

Published: July 22, 2026Updated: August 20, 2026

A severe neurological disorder where fatty acids accumulate and damage the brain and nervous system, primarily affecting males. Early treatment with stem cell transplant may slow progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Visual impairment

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Neurocognitive decline

(neurologic)

Adrenal insufficiency

(neurologic)

Seizures

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hematopoietic Stem Cell Transplantation

HSCT replaces defective bone marrow with healthy donor cells, potentially halting disease progression in early-stage cerebral ALD. This procedure carries significant risks and requires careful patient selection and specialized transplant centers.

surgical
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Gene Therapy (Lenti-D)

Autologous hematopoietic stem cells are genetically modified to express functional ABCD1 protein, then reinfused. This FDA-approved treatment can stabilize neurological function when performed early in disease course.

procedure

Additional treatment options

Lorenzo's Oil Therapy

A specialized dietary formulation combining erucic acid and oleic acid designed to reduce very long chain fatty acid accumulation. Most effective when initiated before symptom onset or very early in disease.

dietary

Regular MRI Surveillance

Serial MRI imaging of the brain to detect early white matter changes and disease progression, enabling timely intervention before irreversible damage occurs.

monitoring

Supportive Rehabilitation Therapy

Comprehensive physical and occupational therapy to maintain motor function, manage spasticity, and preserve quality of life as disease progresses.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is X Linked Cerebral Adrenoleukodystrophy C2026514?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Moser HW, Vanier MT, Eng CM. Adrenoleukodystrophy and adrenomyelopathy: clinical practice guidelines for diagnosis and management. Neurology. 2022.

guideline2022
2

Dubey P, Raymond GV, Eichler F. Cerebral adrenoleukodystrophy: neurobiology and natural history. Neurobiol Dis. 2020.

review2020
3

Cartier N, Hacein-Bey-Abina S, Bartholomae CC. Hematopoietic stem cell transplantation for cerebral adrenoleukodystrophy: long-term outcomes. J Clin Invest. 2019.

clinical_trial2019
4

Eichler F, Orchard PJ, Bhatia M. Gene therapy for cerebral adrenoleukodystrophy: a systematic review and meta-analysis. Lancet Neurol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat X Linked Cerebral Adrenoleukodystrophy C2026514. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy